Product Information
METHOTREXATE 50 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $3.2634 per ML under NDC 61703035010. Its NADAC has been published 316 times since Jun 10, 2020.
Strength
25 mg/mL
Manufacturer
Hospira Inc.NDC
61703035010
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA011719On Market Since
9/25/2014
Pharmacological Classes
Price Statistics
The NADAC for METHOTREXATE 50 MG/2 ML VIAL has been published 316 times since Jun 10, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2634 per ML |
|---|---|
| All-time high | $3.4029 (Feb 16, 2022) |
| All-time low | $2.6573 (Jul 17, 2024) |
| 52-week high | $3.3602 |
| 52-week low | $2.9679 |
| Median price | $3.1788 |
| Average price | $3.1631 |
| Largest weekly change | -20.7% (Jul 17, 2024) |
| Weeks tracked | 316 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHOTREXATE 50 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for METHOTREXATE 50 MG/2 ML VIAL, manufactured by Hospira Inc., is $3.2634 per ML (NDC 61703035010), effective Jun 24, 2026.
How has the price of METHOTREXATE 50 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for METHOTREXATE 50 MG/2 ML VIAL has held within roughly two percent of its current level. It has been tracked across 316 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for METHOTREXATE 50 MG/2 ML VIAL?
Since Jun 10, 2020, the NADAC for METHOTREXATE 50 MG/2 ML VIAL has ranged from a low of $2.6573 (Jul 17, 2024) to a high of $3.4029 (Feb 16, 2022), with a median of $3.1788 per ML.
Are there cheaper alternatives to METHOTREXATE 50 MG/2 ML VIAL?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHOTREXATE 1 GRAM/40 ML VIAL, is $0.6450 per ML — about 80% below METHOTREXATE 50 MG/2 ML VIAL.
Who manufactures METHOTREXATE 50 MG/2 ML VIAL?
METHOTREXATE 50 MG/2 ML VIAL (NDC 61703035010) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification